RGS20 Promotes Tumor Progression through Modulating PI3K/AKT Signaling Activation in Penile Cancer

Table 1

Association between clinicopathologic characteristics and RGS20 expression in PC cohort.

Clinicopathological parameters	RGS20 low expression	RGS20 high expression	value
Age (year)			0.502
≤53	27	21
>53	29	17
Phimosis			0.106
Yes	39	32
No	17	6
Body mass index			0.347
<24	41	31
≥24	15	7
Pathological grade			0.379
G1	43	32
G2 + G3	13	6
Histological subtype			0.101
Usual	32	28
Others	24	10
T stage			0.028
Ta + T1	28	11
T2 + T3	28	27
Nodal status			0.002
Negative	40	15
Positive	16	23
Pelvic metastasis			0.013
No	56	34
Yes	0	4